These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1949053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro mutagenicity of the plasmacytomagenic agent pristane (2,6,10,14-tetramethylpentadecane).
    Felix K, Potter M, Bornkamm GW, Janz S.
    Cancer Lett; 1997 Feb 26; 113(1-2):71-6. PubMed ID: 9065804
    [Abstract] [Full Text] [Related]

  • 3. The uptake of pristane (2,6,10,14-tetramethylpentadecane) into phospholipid bilayers as assessed by NMR, DSC, and tritium labeling methods.
    Gawrisch K, Janz S.
    Biochim Biophys Acta; 1991 Dec 09; 1070(2):409-18. PubMed ID: 1764453
    [Abstract] [Full Text] [Related]

  • 4. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane.
    Janz S, Gawrisch K, Lester DS.
    Cancer Res; 1995 Feb 01; 55(3):518-24. PubMed ID: 7834620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
    Sharma US, Balasubramanian SV, Straubinger RM.
    J Pharm Sci; 1995 Oct 01; 84(10):1223-30. PubMed ID: 8801338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F, Mieda S, Miyamoto Y, Arima H, Uekama K.
    J Pharm Sci; 1999 Oct 01; 88(10):970-5. PubMed ID: 10514341
    [Abstract] [Full Text] [Related]

  • 10. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH, Lee SK, Ki MH, Choi WK, Ahn SK, Shin HJ, Hong CI.
    Int J Pharm; 2004 Mar 19; 272(1-2):79-89. PubMed ID: 15019071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
    Pescitelli G, Bilia AR, Bergonzi MC, Vincieri FF, Di Bari L.
    J Pharm Biomed Anal; 2010 Aug 01; 52(4):479-83. PubMed ID: 20185265
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beta-cyclodextrin/steroid complexation: effect of steroid structure on association equilibria.
    Liu FY, Kildsig DO, Mitra AK.
    Pharm Res; 1990 Aug 01; 7(8):869-73. PubMed ID: 2235884
    [Abstract] [Full Text] [Related]

  • 16. Fusion between enveloped viruses and erythrocyte membranes is induced by the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane).
    Janz S, Shacter E, Herrmann A.
    Cancer Biochem Biophys; 1994 Apr 01; 14(1):1-14. PubMed ID: 7796384
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation.
    Ono N, Hirayama F, Arima H, Uekama K.
    Chem Pharm Bull (Tokyo); 2001 Jan 01; 49(1):78-81. PubMed ID: 11201230
    [Abstract] [Full Text] [Related]

  • 18. Spectrophotometric and electrochemical study of the inclusion complex between beta-cyclodextrin and furnidipine.
    Yáñez C, Salazar R, Núñez-Vergara LJ, Squella JA.
    J Pharm Biomed Anal; 2004 Apr 01; 35(1):51-6. PubMed ID: 15030879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The fluidity of DOPC bilayers and membrane fractions prepared from murine plasmacytoma cells is unchanged after incorporation of pristane (2,6,10,14-tetramethylpentadecane) as assessed by fluorescence polarization analysis.
    Janz S, Krumbiegel M, Gawrisch K.
    Cancer Biochem Biophys; 1992 Nov 01; 13(2):85-92. PubMed ID: 1343851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.